Barrow, Hanley, Mewhinney & Strauss’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,942,539
| Closed | -$46.1M | – | 359 |
|
|
2019
Q1 | $46.1M | Buy |
2,942,539
+112,888
| +4% | +$1.77M | 0.08% | 131 |
|
|
2018
Q4 | $43.6M | Sell |
2,829,651
-49,183
| -2% | -$758K | 0.09% | 129 |
|
|
2018
Q3 | $62M | Buy |
2,878,834
+47,700
| +2% | +$1.03M | 0.1% | 130 |
|
|
2018
Q2 | $68.9M | Sell |
2,831,134
-6,700
| -0.2% | -$163K | 0.11% | 124 |
|
|
2018
Q1 | $48.5M | Sell |
2,837,834
-40,659
| -1% | -$695K | 0.08% | 138 |
|
|
2017
Q4 | $54.5M | Sell |
2,878,493
-1,838,375
| -39% | -$34.8M | 0.08% | 135 |
|
|
2017
Q3 | $83M | Sell |
4,716,868
-25,246,962
| -84% | -$444M | 0.13% | 109 |
|
|
2017
Q2 | $995M | Buy |
29,963,830
+209,848
| +0.7% | +$6.97M | 1.51% | 28 |
|
|
2017
Q1 | $955M | Sell |
29,753,982
-2,701,450
| -8% | -$86.7M | 1.44% | 29 |
|
|
2016
Q4 | $1.18B | Buy |
32,455,432
+5,884,444
| +22% | +$213M | 1.76% | 23 |
|
|
2016
Q3 | $1.22B | Buy |
26,570,988
+3,870,176
| +17% | +$178M | 1.86% | 22 |
|
|
2016
Q2 | $1.14B | Buy |
22,700,812
+13,385,352
| +144% | +$672M | 1.74% | 25 |
|
|
2016
Q1 | $498M | Sell |
9,315,460
-287,003
| -3% | -$15.4M | 0.76% | 42 |
|
|
2015
Q4 | $630M | Buy |
9,602,463
+80,062
| +0.8% | +$5.26M | 0.94% | 40 |
|
|
2015
Q3 | $538M | Sell |
9,522,401
-340,442
| -3% | -$19.2M | 0.83% | 42 |
|
|
2015
Q2 | $583M | Sell |
9,862,843
-327,061
| -3% | -$19.3M | 0.79% | 43 |
|
|
2015
Q1 | $635M | Sell |
10,189,904
-633,211
| -6% | -$39.4M | 0.86% | 43 |
|
|
2014
Q4 | $622M | Buy |
10,823,115
+452,762
| +4% | +$26M | 0.83% | 41 |
|
|
2014
Q3 | $557M | Sell |
10,370,353
-498,417
| -5% | -$26.8M | 0.76% | 43 |
|
|
2014
Q2 | $570M | Sell |
10,868,770
-2,466,997
| -18% | -$129M | 0.77% | 45 |
|
|
2014
Q1 | $705M | Buy |
13,335,767
+1,192,204
| +10% | +$63M | 1.01% | 39 |
|
|
2013
Q4 | $487M | Buy |
12,143,563
+5,383,797
| +80% | +$216M | 0.71% | 45 |
|
|
2013
Q3 | $255M | Buy |
6,759,766
+35,800
| +0.5% | +$1.35M | 0.41% | 50 |
|
|
2013
Q2 | $264M | Buy |
+6,723,966
| New | +$264M | 0.44% | 51 |
|